Showing posts with label Developing World. Show all posts
Showing posts with label Developing World. Show all posts

Tuesday, November 13, 2012

Paper: Are We Prepared For A Pandemic In Low Resource Communities?

 

 

# 6713

 

One of the hard truths about pandemics is that they tend to disproportionately affect developing nations and low resource communities.

 

Back in 2006 we looked at a study that appeared in The Lancet that predicted, based on the 1918 pandemic experience, that a modern pandemic of similar virulence could claim 62 million lives, and that 96% of those deaths would occur in the developing world.

 

Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918—20 pandemic: a quantitative analysis

Prof Christopher JL Murray DPhil , Prof Alan D Lopez PhD, Brian Chin ScB, Dennis Feehan AB , Prof Kenneth H Hill PhD

 

The authors cited as much as a 30-fold difference in mortality rates around the world in 1918. Countries in Asia, Latin America, and Sub-Saharan African were particularly hard hit.

 

Some of the reasons behind this disparity included.

 

  • lack of access to adequate medical care
  • weak public health infrastructures,
  • housing conditions and population density
  • nutritional status and
  • co-existing medical conditions.

 

For the most part many of these conditions still persist, plus developed nations today are more likely to have earlier access to antibiotics, antivirals, and eventually vaccines. Leading the authors to write:

 
Interpretation

This analysis of the empirical record of the 1918—20 pandemic provides a plausible upper bound on pandemic mortality. Most deaths will occur in poor countries—ie, in societies whose scarce health resources are already stretched by existing health priorities.

 

 

A grim scenario, and part of the rationale behind the creation of a program called the H2P  (Humanitarian Pandemic Preparedness) Initiative geared towards promoting community & district-level pandemic flu preparedness and response in developing countries.

 

 

H2P (which began in 2007 & ended in 2010) was a joint effort by NGO’s and partner organizations, including USAID, IFRC, CORE Group (including American Red Cross, CARE, & Save the Children), AED, InterAction, & several UN agencies, including WHO, WFP, & UN OCHA.

 

During the 2009 pandemic I highlighted the H2P initiative’s efforts several times (see here, here, and here), and over the years have had occasional correspondence with Eric Starbuck at Save The Children, who was the H2P’s Public Health Advisor with the CORE Group.

 

I mention this past association because Eric is the lead author on a paper that appears today in the Journal Influenza and Other Respiratory Viruses, that looks at the challenges (and provides some solutions) for helping low resource communities deal with an influenza pandemic.

 


The full article is available online, and is well worth reading in its entirety. 

 

Are we prepared to help low-resource communities cope with a severe influenza pandemic?

Eric S. Starbuck, Rudolph von Bernuth, Kathryn Bolles, Jeanne Koepsell

Article first published online: 12 NOV 2012

Recent research involving lab-modified H5N1 influenza viruses with increased transmissibility and the ongoing evolution of the virus in nature should remind us of the continuing importance of preparedness for a severe influenza pandemic.

 

Current vaccine technology and antiviral supply remain inadequate, and in a severe pandemic, most low-resource communities will fail to receive adequate medical supplies.

 

However, with suitable guidance, these communities can take appropriate actions without substantial outside resources to reduce influenza transmission and care for the ill. Such guidance should be completed, and support provided to developing countries to adapt it for their settings and prepare for implementation.

View Full Article (HTML)     Get PDF (71K)

 

In regions where antivirals, antibiotics, and vaccines (and even basic nursing care) may be unavailable, the only realistic protection against an influenza pandemic is the implementation of NPIs (Non-Pharmaceutical Interventions). 

 

We’ve talked about NPIs many times before, but primarily in the context of a developed or industrialized community.

 

NPI’s and Influenza

Our First Line Of Defense
Study: Effectiveness of NPIs Against ILI's

 

As Eric and his team point out:

 

Nonpharmaceutical interventions (NPIs) to reduce influenza transmission at the household level may include keeping a distance from others, washing hands, covering one’s cough, and isolation of the ill.

 

However, several of these NPIs may not be very feasible in some settings, such as those with poor access to water or where many families live in small one-room dwellings.

 

Experience during the 2009 pandemic indicates that communication materials, such as those encouraging the practice of these NPIs, need to be adapted, tested, and approved for local use ahead of time. The absence of standardized, pretested messages was a challenge in 2009

 

A few samples of the type of guidance provided by H2P to low resource communities include:

 

image

image

 

The authors conclude:

 

We believe that detailed authoritative guidance for resource-poor settings on NPIs to reduce influenza transmission at community level in a severe pandemic should be developed.

 

In addition, support should be provided to governments in developing countries to adapt this and other important guidance to their settings and plan to roll it out if needed.

 

We are not aware of ongoing efforts of this kind, but believe that this should be an urgent priority. We are concerned about this apparent gap in the most basic kind of preparedness for a severe pandemic.

 


 

It doesn’t take a pandemic to put people living in low resource communities at greater risk. That happens every day.

 

Agencies like the Red Cross, Red Crescent, CARE, Save The Children, UNICEF, and others are working around the world on a daily basis to combat poverty and disease, and are going to be on the front lines during any pandemic.

 

They could use your support.

 

These NGO’s do a great deal with very little, and even small donations can help make a difference.

 


A final note: For those curious about my mention in the acknowledgements section of this paper, I assure you my contribution was small, and unworthy of mention (but I’m appreciative, nonetheless). When asked, I suggested to Eric that the Journal Influenza and Other Respiratory Viruses might be interested in his paper.

Sunday, April 17, 2011

WHO Video: A Vaccine Story

 

 

# 5498

 

 

We are just now coming up on the 2-year anniversary of the emergence of the novel H1N1 `swine’ flu virus which sparked the first pandemic of the 21st century.

 

Although the pandemic has been officially declared over since last August, agencies and investigators continue to review what went right and what went wrong in our global response.

 

Last month (see IHR Review Committee Report On The Pandemic Of 2009) we saw an independent review of the World Health Organization’s  pandemic response that gave the organization a mixed grade; finding that the WHO did well in some areas and not as well in others.

 

 

This month the World Health Organization has released a glossy new 15-minute video showing their behind-the-scenes efforts to deploy pandemic influenza vaccine to developing nations around the globe.

 

A VACCINE STORY is more of a promotional film than a documentary, and understandably shows this vaccine distribution program in the best possible light. 

 

It does, however, give the viewer a look at some of the logistics involved in delivering a vaccine to poorer nations during a pandemic.   

 

image

(Click image to Open Youtube Video)

 

 

While this film stresses that this program managed to get roughly 78 million doses of vaccine distributed to 77 developing nations, that fell far short of the goals announced at the start of the pandemic.  

 

Late last month Margaret Chan, Director-General of the WHO, focused attention on some of the external obstacles they faced in this admittedly complex and difficult endeavor.

 

 

WHO blames drug industry for swine flu vaccine delay

Mon Mar 28, 2011 4:51pm GMT

* WHO's Chan blames others for delay in vaccine distribution

* Agency distributed 78 million doses to 77 poor countries

 

 

In my next blog I’ll take a look at some of the difficulties of vaccine distribution encountered during the last pandemic, and the prospects for deployment should another virus emerge in the near future.

Wednesday, January 06, 2010

WHO Reassessing Vaccine Distribution Needs

 

 

# 4226

 

 

What a difference six months makes.

 

Last summer, when the WHO (World Health Organization) had just declared the start of the 2009 pandemic, countries all around the world were clamoring for what was obviously going to be a limited amount of vaccine. 


Fast forward to the end of 2009, and the demand for the vaccine is visibly softening.   Countries that ordered on the basis of expecting to need two doses for each adult, and higher uptake by their populations, are now trying to cut back on those orders.

 

And even developing countries that once coveted the scarce vaccine are beginning to have second thoughts.

 

This report from Helen Branswell of the Canadian Press.  As always with a Branswell article, follow the link to read it in its entirety.

 

 

WHO-led H1N1 vaccine redistribution may be scaled back as countries reassess need

By Helen Branswell Medical Reporter (CP)

TORONTO — Softening demand for H1N1 vaccine may be spreading to a World Health Organization-led effort to provide developing countries with some pandemic vaccine, a WHO official said Tuesday.

 

Dr. Marie-Paule Kieny said some recipient countries appear to be reassessing how much donated H1N1 vaccine they want because of shifting perceptions of the benefits of using significant amounts of vaccine at this point.

 

The WHO had hoped to provide vaccine for up to 10 per cent of the populations of developing countries that wanted donated vaccine. But whether recipient countries want that much vaccine at this point isn't clear, "in view of the trend of the epidemic."

 

"And it's normal. There is a need for reassessment of what the epidemiology is telling us," Kieny said in an interview from Geneva.

 

"Of course we cannot rule out that there will be another peak. And we don't know exactly what will happen in the Southern Hemisphere when they start (their next winter) also."

 

(Continue . . . )

Tuesday, November 10, 2009

WHO: GSK Signs Vaccine Donation Agreement

 

 

# 3984

 

 

The World Health Organization’s plan to collect and distribute donated vaccine to nearly 100 developing nations got a shot in the arm today with the signing of a formal agreement with GSK (GlaxoSmithKline) for the delivery of 50 million doses over the next six months.

 

While this donation, along with as many as 100 million additional expected doses from other manufacturers and nations, won’t be enough for the developing world . .. it is a start.

 

 

Statement
10 November 2009

Agreement for donation of pandemic H1N1 vaccine signed

 

GlaxoSmithKline(GSK) is to donate 50 million doses of pandemic H1N1 vaccine to the World Health Organization (WHO) under an agreement signed at WHO headquarters in Geneva by the WHO Director-General, Dr Margaret Chan, and the Chief Executive Officer of GlaxoSmithKline, Mr Andrew Witty.

 

"We welcome this very generous donation by GlaxoSmithKline, which will go to protect the health of the world's poorest people. This is a real gesture of global solidarity towards those who would not be otherwise able to have access to the vaccine," said Dr. Margaret Chan. "WHO will now work to see that these vaccines are distributed to those who need them."

 

GSK expects to prepare the first shipments of vaccine to the WHO by the end of November. The WHO has a list of 95 developing countries that are eligible to receive donated vaccines, and aims to secure enough vaccines to cover 10 percent of the population of these countries.

 

 

And from the Associated Press, this report indicating that this donated vaccine will ship between late November and May.

 

Nov 10, 7:23 AM EST

WHO: Glaxo vaccine donation shipping thru May

 

GENEVA (AP) -- The World Health Organization says it expects GlaxoSmithKline to complete shipping donations of swine flu vaccine to poor countries by May 2010.

 

WHO spokesman Gregory Hartl said Tuesday the global body hopes countries will start receiving the first of 50 million doses from Glaxo in late November or early December.

Thursday, September 17, 2009

Developed Nations To Donate 10% of Swine Flu Vaccine

 

 

# 3747

 

 

While I was out getting my seasonal flu shot (hint . . hint), this little piece of encouraging news came across the wires.

 

 

Developed Nations to Donate Swine-Flu Shots to Poorer Countries

 

By Phil Serafino

Sept. 17 (Bloomberg) -- Developed nations agreed to donate swine flu vaccine to poorer countries now that studies indicate one shot will provide protection from the virus.

 

France will donate 9 million doses, or about 10 percent of its 94-million-dose stockpile, to the World Health Organization, President Nicolas Sarkozy’s office said in an e-mailed statement today. The U.S. also will donate 10 percent of its supplies, according to a statement from the White House.

 

France, Italy, Norway, the U.S., the U.K., Brazil, Australia, New Zealand and Switzerland are working together on the donation, according to the U.S. statement.

 

(Continue . . .)

 

 

While 10% of the vaccine ordered by these developed nations isn’t enough to satisfy the needs of the developing world, it does represent tens of millions of doses that a week ago would not have been available to them otherwise.  

 

Perhaps, if the uptake of the vaccine in developed countries is less than anticipated, we’ll  see additional donations down the line. 

 

But for now . . it’s a start.

 

Speaking of vaccines. 

 

The Reveres at Effect Measure weigh in today on the rationale behind getting the seasonal vaccine, even though it isn’t clear how big a player the existing seasonal viruses will be this year.

 

Seasonal flu: Why I got vaccinated

 

While I’d intended to get the shot this year anyway, their arguments (and reminder) prompted me to go out and get my shot today. 

 

One thing that I noticed is you you can’t drive 3 blocks in my town without seeing some Big Box store, some grocery store, or pharmacy offering flu shots.   Makes it pretty easy.

 

 Just do it.

 

image